MedPath

Cognitive Function Training Using Smartphone Applications for Patients with Mild Cognitive Impairment

Not Applicable
Active, not recruiting
Conditions
Mental and behavioural disorders
Registration Number
KCT0008311
Lead Sponsor
Hallym University Medical Center- Chuncheon
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Active, not recruiting
Sex
All
Target Recruitment
90
Inclusion Criteria

A) Adult men and women aged 18 years or older
B) Patients or guardians complain of memory loss
C) Through neuropsychological tests, cognitive ability, including memory, is reduced compared to age and education level.
D) Maintain overall cognitive function
E) No hindrance to daily life
F) It should not be dementia according to the judgment of the clinician
G) Subjects or their legal representatives voluntarily decide to participate in the study and give written consent after listening to a detailed explanation of this study and fully understanding it

Exclusion Criteria

a) any advanced, severe, progressive or unstable disease that could put the patient at risk;
B) Any medical or other neurological disease that can explain cognitive decline (e.g., abnormal thyroid function test, vitamin B12 or folic acid deficiency, post-traumatic disease, Huntington's disease, multiple sclerosis, cerebral palsy, encephalitis, meningitis, etc. - diseases affecting the central nervous system)
c) any other DSM-V Axis I diagnosis, including primary neurodegenerative dementia other than depression, schizophrenia, or bipolar disorder
D) Those who currently have uncontrolled convulsive disease
E) A person who has a history of loss of consciousness for more than 1 hour or a brain injury accident that resulted in hospitalization within 3 years
F) Hearing or vision impairment that may interfere with the performance of the requirements of the clinical trial
G) Those who are judged not to be suitable for research according to the judgment of the researcher

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ADAS-Cog 13 total points
Secondary Outcome Measures
NameTimeMethod
ADAS-Cog 13 score by domain, ADCS-ADL-MCI score , K-MMSE 2, CDR, GDeS
© Copyright 2025. All Rights Reserved by MedPath